大型试验证实了甲型H1N1流感疫苗的免疫原性。 - Suppr

Suppr

超能文献

Large trials confirm immunogenicity of H1N1 vaccines.

作者信息

Kelly Heath, Barr Ian

机构信息

Epidemiology Unit, Victorian Infectious Diseases Reference Laboratory, Melbourne, VIC 3051, Australia.

出版信息

Lancet. 2010 Jan 2;375(9708):6-9. doi: 10.1016/S0140-6736(09)62132-2. Epub 2009 Dec 15.

DOI:10.1016/S0140-6736(09)62132-2

PMID:20018366

Abstract

摘要

相似文献

Large trials confirm immunogenicity of H1N1 vaccines.

Lancet. 2010 Jan 2;375(9708):6-9. doi: 10.1016/S0140-6736(09)62132-2. Epub 2009 Dec 15.

[Serological survey of pandemic influenza A (H1N1) virus infection among population in Hunan Province].

Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi. 2011 Feb;25(1):17-9.

Assessment of the immunogenicity and safety of varying doses of an MF59®-adjuvanted cell culture-derived A/H1N1 pandemic influenza vaccine in Japanese paediatric, adult and elderly subjects.

Vaccine. 2012 Jul 13;30(33):5030-7. doi: 10.1016/j.vaccine.2012.03.053. Epub 2012 Apr 1.

Pre-vaccination immunity and immune responses to a cell culture-derived whole-virus H1N1 vaccine are similar to a seasonal influenza vaccine.

Vaccine. 2012 Jun 22;30(30):4543-51. doi: 10.1016/j.vaccine.2012.03.061. Epub 2012 Apr 1.

Immunogenicity and safety of a monovalent vaccine for the 2009 pandemic influenza virus A (H1N1) in children and adolescents.

Vaccine. 2010 Aug 16;28(36):5864-70. doi: 10.1016/j.vaccine.2010.06.059. Epub 2010 Jul 13.

A/H1N1 influenza vaccination in patients with systemic lupus erythematosus: safety and immunity.

Vaccine. 2011 Jan 10;29(3):444-50. doi: 10.1016/j.vaccine.2010.10.081. Epub 2010 Nov 13.

Safety and immunogenicity of 2009 pandemic influenza A H1N1 vaccines in China: a multicentre, double-blind, randomised, placebo-controlled trial.

Lancet. 2010 Jan 2;375(9708):56-66. doi: 10.1016/S0140-6736(09)62003-1. Epub 2009 Dec 15.

Immunogenicity of inactivated 2009 H1N1 influenza vaccine in pediatric liver transplant recipients.

Vaccine. 2011 Jun 6;29(25):4187-9. doi: 10.1016/j.vaccine.2011.04.012. Epub 2011 Apr 20.

Immune response after a single vaccination against 2009 influenza A H1N1 in USA: a preliminary report of two randomised controlled phase 2 trials.

Lancet. 2010 Jan 2;375(9708):41-8. doi: 10.1016/S0140-6736(09)62026-2. Epub 2009 Dec 15.

Responses to 2009 H1N1 vaccine in children 3 to 17 years of age.

N Engl J Med. 2010 Jan 28;362(4):370-2. doi: 10.1056/NEJMc0909988. Epub 2009 Dec 30.

引用本文的文献

Burden, effectiveness and safety of influenza vaccines in elderly, paediatric and pregnant populations.

Ther Adv Vaccines Immunother. 2019 Feb 7;7:2515135519826481. doi: 10.1177/2515135519826481. eCollection 2019.

A phase II study of an investigational tetravalent influenza vaccine formulation combining MF59®: adjuvanted, pre-pandemic, A/H5N1 vaccine and trivalent seasonal influenza vaccine in healthy adults.

Hum Vaccin Immunother. 2014;10(1):92-9. doi: 10.4161/hv.26495. Epub 2013 Sep 20.

Moderate influenza vaccine effectiveness with variable effectiveness by match between circulating and vaccine strains in Australian adults aged 20-64 years, 2007-2011.

Influenza Other Respir Viruses. 2013 Sep;7(5):729-37. doi: 10.1111/irv.12018. Epub 2012 Oct 19.

Meta-analysis of the immunogenicity and tolerability of pandemic influenza A 2009 (H1N1) vaccines.

PLoS One. 2011;6(9):e24384. doi: 10.1371/journal.pone.0024384. Epub 2011 Sep 6.

Vaccination against seasonal influenza A/H3N2 virus reduces the induction of heterosubtypic immunity against influenza A/H5N1 virus infection in ferrets.

J Virol. 2011 Mar;85(6):2695-702. doi: 10.1128/JVI.02371-10. Epub 2011 Jan 12.

An open-label, randomized clinical trial assessing immunogenicity, safety and tolerability of pandemic influenza A/H1N1 MF59-adjuvanted vaccine administered sequentially or simultaneously with seasonal virosomal-adjuvanted influenza vaccine to paediatric kidney transplant recipients.

Nephrol Dial Transplant. 2011 Jun;26(6):2018-24. doi: 10.1093/ndt/gfq657. Epub 2010 Oct 25.

Safety and immunogenicity of AS03B adjuvanted split virion versus non-adjuvanted whole virion H1N1 influenza vaccine in UK children aged 6 months-12 years: open label, randomised, parallel group, multicentre study.

BMJ. 2010 May 27;340:c2649. doi: 10.1136/bmj.c2649.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验